🇺🇸 FDA

Drug profile · INN

zidovudine

ZIDOVUDINE

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

zidovudine (ZIDOVUDINE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

Key facts

INN zidovudine
Brand ZIDOVUDINE
Route INJECTION
Formulation CAPSULE
Originator Regeneron Ireland Designated Activity Company (DAC)

Related patents

Search patents →

  1. US 12404505

    Delivery of a gene-editing system with a single retroviral particle and methods of generation and use

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12280063

    Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11814641

    Retroviral and lentiviral vectors

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11744831

    Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11591613

    Retroviral and lentiviral vectors

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11135283

    Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11065254

    Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10954530

    Retroviral and lentiviral vectors

    Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is zidovudine?

zidovudine (ZIDOVUDINE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

What is the brand name for zidovudine?

ZIDOVUDINE is a marketed brand name for zidovudine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of zidovudine?

zidovudine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.